Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249553
Max Phase: Preclinical
Molecular Formula: C47H69N13O10
Molecular Weight: 976.15
Molecule Type: Protein
Associated Items:
ID: ALA3249553
Max Phase: Preclinical
Molecular Formula: C47H69N13O10
Molecular Weight: 976.15
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N(C)CC(=O)N[C@@H](Cc1ccccc1)C(=O)O
Standard InChI: InChI=1S/C47H69N13O10/c1-7-28(4)40(44(67)57-35(22-31-23-51-26-53-31)45(68)60(6)25-38(63)55-36(46(69)70)21-29-12-9-8-10-13-29)59-42(65)34(20-30-15-17-32(61)18-16-30)56-43(66)39(27(2)3)58-41(64)33(54-37(62)24-50-5)14-11-19-52-47(48)49/h8-10,12-13,15-18,23,26-28,33-36,39-40,50,61H,7,11,14,19-22,24-25H2,1-6H3,(H,51,53)(H,54,62)(H,55,63)(H,56,66)(H,57,67)(H,58,64)(H,59,65)(H,69,70)(H4,48,49,52)/t28-,33-,34-,35-,36-,39-,40-/m0/s1
Standard InChI Key: CQNGGOVUHUAAGS-VPZARLNTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 976.15 | Molecular Weight (Monoisotopic): 975.5290 | AlogP: -1.22 | #Rotatable Bonds: 29 |
Polar Surface Area: 355.05 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.89 | CX Basic pKa: 11.47 | CX LogP: -3.15 | CX LogD: -4.09 |
Aromatic Rings: 3 | Heavy Atoms: 70 | QED Weighted: 0.02 | Np Likeness Score: -0.16 |
1. Moore GJ, Oudeman EM, Ko D, Nystrom DM.. (1979) Synthesis of angiotensin II antagonists containing sarcosine in position 7., 22 (9): [PMID:490564] [10.1021/jm00195a032] |
Source(1):